LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01)

Journal of Medical Virology

Volumn 81, Issue 2, 2009, Pages 217-223

  Avettand Fènoë, Véronique ^a,b   Chaix, Marie Laure ^a,b   Blanche, Stéphane ^a,b   Burgard, Marianne ^a,b   Floch, Corinne ^c   Toure, Kadidia ^d   Allemon, Marie Christine ^e   Warszawski, Josiane ^f   Rouzioux, Christine ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL LOUIS MOURIER   (France)

^d Centre Hospitalier d'Evreux   (France)

^e DELAFONTAINE HOSPITAL   (France)

^f BICÊTRE HOSPITAL   (France)

Author keywords

Diagnosis in infants; HIV 1 DNA quantitation; LTR real time PCR; Whole blood

Indexed keywords

ABACAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS DNA;

ARTICLE; BLOOD CELL; CLINICAL TRIAL; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; LEUKOCYTE; MAJOR CLINICAL STUDY; NEWBORN; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; ADULT; BLOOD; DISEASE TRANSMISSION; FEMALE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MONONUCLEAR CELL; MOTHER; POLYMERASE CHAIN REACTION; PREGNANCY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIROLOGY;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; MOTHERS; POLYMERASE CHAIN REACTION; PREGNANCY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 61749103775     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21390     Document Type: Article

References (19)

1. Désiré N, Dehée A, Schneider V, Jacomet C, Goujon C, Girard PM, Rozenbaum W, Nicolas JC. 2001. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan realtime PCR assay. J Clin Microbiol 39:1303-1310.
2. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154.
3. Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, Rabson A, Daugherty D, Gendelman HE, Hoggan MD, Venkatesan S, Martin MA. 1986. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 164:280-290.
4. Garrigue I, Pellegrin I, Hoen B, Dumon B, Harzic M, Schrive MH, Séréni D, Fleury H. 2000. Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA. AIDS 14:2851-2855.
5. Germer JJ, Gerads TM, Mandrekar JN, Mitchell PS, Yao JD. 2006. Detection of HIV-1 proviral DNA with the AMPLICOR HIV-1 DNA Test, version 1.5, following sample processing by the MagNA Pure LC instrument. J Clin Virol 37:195-198.
6. Ginsburg AS, Miller A, Wilfert CM. 2006. Diagnosis of pediatric human immunodeficiency virus infection in resource-constrained settings. Pediatr Infect Dis J 25:1057-1064.
7. Jennings C, Danilovic A, Scianna S, Brambilla DJ, Bremer JW. 2005. Stability of human immunodeficiency virus type 1 proviral DNA in whole-blood samples. J Clin Microbiol 43:4249-4250.
8. Kabamba-Mukadi B, Henrivaux P, Ruelle J, Delferrière N, Bodéus M, Goubau P. 2005. Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR. BMC Infect Dis 5:15.
9. Lillo FB, Grasso MA, Lodini S, Bellotti MG, Colucci G. 2004. Few modifications of the Cobas Amplicor HIV Monitor 1.5 test allow reliable quantitation of HIV-1 proviral load in peripheral blood mononuclear cells. J Virol Methods 120:201-205.
10. MSF International AIDS Working Group. 2007. Prevention of Mother to Child Transmission - Recommendations for MSF programs.
11. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. 2004. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis. Lancet 364:1236-1243.
12. Ngo-Giang-Huong N, Deveau C, Da Silva I, Pellegrin I, Venet A, Harzic M, Sinet M, Delfraissy JF, Meyer L, Goujard C, Rouzioux C. 2001. Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after 1 year of highly active antiretroviral therapy. AIDS 15:665-673.
13. Ometto L, De Forni D, Patiri F, Trouplin V, Mammano F, Giacomet V, Giaquinto C, Douek D, Koup R, De Rossi A. 2002. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: Role of thymic output and viral fitness. AIDS 16:839-849.
14. Pellegrin I, Caumont A, Garrigue I, Merel P, Schrive MH, Fleury H, Dupon M, Pellegrin JL, Ragnaud JM. 2003. Predictive value of provirus load and DNA human immunodeficiency virus genotype for successful abacavir-based simplified therapy. J Infect Dis 187:38-46.
15. Rouet F, Sakarovitch C, Msellati P, Elenga N, Montcho C, Viho I, Blanche S, Rouzioux C, Dabis F, Leroy V. 2003. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics 112:e289.
16. Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, Peeters M, Damond F, Ekouevi DK, Msellati P, Ferradini L, Rukobo S, Maréchal V, Schvachsa N, Wakrim L, Rafalimanana C, Rakotoambinina B, Viard JP, Seigneurin JM, Rouzioux C. 2007. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr 45:380-388.
17. World Health Organisation. 2006. Recommendations on the diagnosis of HIV infection in infants and children. Draft for public review. Geneva: WHO.
18. Zhang Q, Wang L, Jiang Y, Fang L, Pan P, Gong S, Yao J, Tang YW, Vermund SH, Jia Y. 2008. Early infant human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex DNA PCR and dried blood spots. J Clin Microbiol 46:721-726.
19. Zhao Y, Yu M, Miller JW, Chen M, Bremer EG, Kabat W, Yogev R. 2002. Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology. J Clin Microbiol 40:675-678.